Ara
Toplam kayıt 26, listelenen: 21-26
Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
(Soc Brasileira Dermatologia, 2017)
Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal ...
Pustular eruption induced by etanercept in a patient with ankylosing spondylitis: a rare side effect
(Kare Publ, 2015)
Etanercept is a tumor necrosis factor alpha (TNF-alpha) antagonist with anti-inflammatory effects. It is used in the treatment of dermatologic and rheumatologic diseases such as rheumatoid arthritis, polyarticular juvenile ...
Primer malignant giant cell tumour of kidney: a case report
(The Royal College of Surgeons of England, 2021)
Osteoclast-like giant cell tumours of the kidney are extremely rare and usually accompanied by a conventional urothelial neoplasm such as papillary, transitional renal cell, or sarcomatoid carcinoma. Although they have ...
Serum soluble Fas-ligand levels and flow-mediated vasodilation in patients undergoing peritoneal dialysis
(State Institution Institute of Nephrology of the National Academy of Medical Science of Ukraine, 2022)
Flow-mediated vasodilation (FMD) has been demonstrated to be a useful, non-invasive tool for the detection ofendothelialdysfunction in atherosclerotic cardiovascular disease, the leading cause of mortality in end-stage ...
Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren's syndrome murine model
(Plos, 2022)
Objective: Dental mesenchymal stem cells (MSCs) are potential for use in tissue regeneration in inflammatory diseases due to their rapid proliferating, multilineage differentiation, and strong anti-inflammatory features. ...
Survival outcomes of hypomethylating agents maintenance therapy in new diagnosed AML patients: Real experience data
(PMC, 2022)
Objective: Acute myeloid leukemia (AML) is a hematological malignancy that frequently affects elderly population. With introducing the hypomethylating agents (HMAs) in elderly AML treatment, survival rates and quality of ...